©The Author(s) 2025.
World J Stem Cells. Feb 26, 2025; 17(2): 100621
Published online Feb 26, 2025. doi: 10.4252/wjsc.v17.i2.100621
Published online Feb 26, 2025. doi: 10.4252/wjsc.v17.i2.100621
Table 3 Toxicity in patients with solid tumors who underwent tandem autologous stem cell transplantation, n (%)
| Parameter | First ASCT | Second ASCT | ||
| Group A (n = 21) | Group B (n = 19) | Group A (n = 21) | Group B (n = 19) | |
| Hematologic toxicity | ||||
| Fever (BT ≥ 38.0 °C) | 17 (81.1) | 18 (94.7) | 17 (80.1) | 16 (84.2) |
| Septicemia | 2 (9.5) | 1 (5.3) | 0 (0) | 0 (0) |
| Non-hematologic toxicity | ||||
| Mucositis | 1 (4.8) | 3 (15.8) | 2 (9.5) | 5 (26.3) |
| Vomiting | 14 (66.7) | 16 (84.2) | 12 (57.1) | 11 (57.9) |
| Diarrhea | 10 (47.6) | 13 (68.4) | 10 (47.6) | 11 (57.9) |
| Elevated liver enzymes | 4 (19.0) | 4 (21.1) | 1 (4.7) | 4 (21.1) |
| Renal insufficiency | 0 (0) | 1 (5.3) | 0 (0) | 1 (5.3) |
| Hypokalemia | 5 (23.8) | 10 (52.6) | 2 (9.5) | 4 (21.1) |
| Hypomagnesemia | 8 (38.0) | 6 (31.6) | 7 (33.3) | 2 (10.5) |
| Hepatic VOD | 0 (0) | 0 (0) | 0 (0) | 3 (15.8) |
| Myocarditis | 2 (9.5) | 1 (5.3) | 0 (0) | 0 (0) |
| Treatment-related mortality | 0 | 0 | ||
- Citation: Luo ZY, Fan LQ, Guo WL, Yang JP, Li ZY, Huang YX, Jiang H, Zhang XH. Effect of tandem autologous stem cell transplantation on survival in pediatric patients with high-risk solid tumors in South China. World J Stem Cells 2025; 17(2): 100621
- URL: https://www.wjgnet.com/1948-0210/full/v17/i2/100621.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i2.100621